Skip to main content

CORRECTION article

Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1538349

Corrigendum: Research progress of CD80 in the development of immunotherapy drugs

Provisionally accepted
Lanying Li Lanying Li Lei Yang Lei Yang De Peng Jiang De Peng Jiang *
  • Second Affiliated Hospital, Chongqing Medical University, Chongqing, China

This article is a correction to:

  1. Corrigendum:Research progress of CD80 in the development of immunotherapy drugs

    1. Read original article

The final, formatted version of the article will be published soon.

    • please read through all the templates before choosing• pick the most relevant text template(s) from the following page and delete all others.• edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below.• please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary• submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. There was a mistake in the Funding statement, an incorrect number was used. The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated.

    Keywords: CD80, immunotherapy drugs, T cells, tumor, Autoimmune Diseases

    Received: 02 Dec 2024; Accepted: 03 Dec 2024.

    Copyright: © 2024 Li, Yang and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: De Peng Jiang, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.